Year archive

MICROBA LIFE SCIENCES LIMITED — 2022 filings

All 101 regulatory filings released by MICROBA LIFE SCIENCES LIMITED (MAP) in 2022, sourced directly from the official regulator.

101 Filings

2022 Period

2022 filings (101)

Filing	Released	Lang
Letter to Shareholders, Notice of Meeting & Proxy Form 18 pages 628.5KB Regulatory Filings	2022-12-19	English
SYNLAB Agreements Signed in Italy and Portugal 2 pages 166.7KB Regulatory Filings	2022-12-07	English
Change in substantial holding from TEK 5 pages 198.6KB Regulatory Filings	2022-12-04	English
Change in substantial holding - Tiga Trading Pty Ltd 4 pages 157.2KB Regulatory Filings	2022-12-04	English
Becoming a substantial holder from SHL 38 pages 684.2KB Regulatory Filings	2022-12-01	English
Change in substantial holding 2 pages 813.2KB Regulatory Filings	2022-12-01	English
Change in substantial holding 2 pages 622.9KB Regulatory Filings	2022-12-01	English
Change in substantial holding 6 pages 379.7KB Regulatory Filings	2022-12-01	English
Change in substantial holding 2 pages 246.5KB Regulatory Filings	2022-12-01	English
Change in substantial holding 2 pages 716.4KB Regulatory Filings	2022-12-01	English
Ceasing to be a substantial holder 1 page 219.1KB Regulatory Filings	2022-12-01	English
Application for quotation of securities - MAP 6 pages 28.2KB Regulatory Filings	2022-11-30	English
Cleansing Notice 1 page 232.2KB Regulatory Filings	2022-11-30	English
Sonic Acquires 19.9% Microba Stake and Enters Partnership 3 pages 187.6KB Regulatory Filings	2022-11-28	English
Sonic Investment & Partnership Investor Presentation 17 pages 2.2MB Regulatory Filings	2022-11-28	English
Proposed issue of securities - MAP 5 pages 28.1KB Regulatory Filings	2022-11-28	English
Proposed issue of securities - MAP 6 pages 29.5KB Regulatory Filings	2022-11-28	English
SHL: STRATEGIC STAKE AND COMMERCIAL PARTNERSHIP WITH MICROBA 1 Regulatory Filings	2022-11-28	English
Trading Halt 2 pages 210.0KB Regulatory Filings	2022-11-27	English
2022 AGM Presentations 18 pages 1.9MB Regulatory Filings	2022-11-24	English
Results of AGM 2 pages 154.7KB Regulatory Filings	2022-11-24	English
Change of Director's Interest Notice - Prof Ian Frazer 2 pages 182.5KB Regulatory Filings	2022-11-07	English
Change of Director's Interest Notice - Pasquale Rombola 2 pages 161.5KB Regulatory Filings	2022-11-07	English
Microba receives $2.62m R&D Tax Incentive refund 1 Regulatory Filings	2022-10-31	English
Investor Presentation Q1 FY23 Update 16 pages 1.9MB Regulatory Filings	2022-10-30	English
Q1 FY23 Quarterly Activities Report & Appendix 4C 10 pages 388.2KB Regulatory Filings	2022-10-26	English
Details of Q1 FY23 Investor Webinar 1 page 179.0KB Regulatory Filings	2022-10-26	English
Change in substantial holding from TEK 5 pages 182.6KB Regulatory Filings	2022-10-25	English
Change in substantial holding - Tiga Trading Pty Ltd 4 pages 157.7KB Regulatory Filings	2022-10-25	English
Change in substantial holding 2 pages 810.7KB Regulatory Filings	2022-10-24	English
Letter to Shareholders, Notice of AGM & Proxy Form 23 pages 585.9KB Regulatory Filings	2022-10-24	English
Annual Report to Shareholders 77 pages 10.0MB Regulatory Filings	2022-10-24	English
Microba, SYNLAB Extend & Expand Distribution 2 pages 213.1KB Regulatory Filings	2022-10-19	English
Ceasing to be a substantial holder 3 pages 33.9KB Regulatory Filings	2022-10-18	English
Investor Presentation October 2022 15 pages 1.5MB Regulatory Filings	2022-10-16	English
Date of AGM and Closing Date for Director Nominations 1 Regulatory Filings	2022-10-06	English
Release of Restricted Securities 1 page 130.1KB Regulatory Filings	2022-09-26	English
Director Appointment - Jacqueline Fernley 1 page 1 Regulatory Filings	2022-09-07	English
Initial Director's Interest Notice - Jacqueline Fernley 2 pages 153.1KB Regulatory Filings	2022-09-07	English
Becoming a substantial holder from TEK 5 pages 218.6KB Regulatory Filings	2022-09-05	English
Becoming a substantial holder - Tiga Trading Pty Ltd 5 pages 193.3KB Regulatory Filings	2022-09-05	English
Change in substantial holding 2 pages 809.3KB Regulatory Filings	2022-09-04	English
Therapeutic Program Advancement 2 pages 176.2KB Regulatory Filings	2022-08-30	English
Investor Presentation - FY22 Update Annual Results 28 pages 2.6MB Regulatory Filings	2022-08-29	English
Appendix 4E & Annual Report 79 pages 10.0MB Regulatory Filings	2022-08-24	English
Corporate Governance Statement 14 pages 241.6KB Regulatory Filings	2022-08-24	English
Appendix 4G 13 pages 325.9KB Regulatory Filings	2022-08-24	English
Change in substantial holding 3 pages 37.5KB Regulatory Filings	2022-08-22	English
Change in substantial holding 2 pages 813.7KB Regulatory Filings	2022-08-18	English
Microba receives two AusIndustry Advanced Overseas Findings 2 pages 165.6KB Regulatory Filings	2022-07-21	English
Q4 FY22 Quarterly Activities Report & Appendix 4C 9 pages 343.8KB Regulatory Filings	2022-07-19	English
Investor Update - Q4 FY22 Results 26 pages 2.5MB Regulatory Filings	2022-07-19	English
Details of Q4 FY22 Investor Webinar 1 page 180.2KB Regulatory Filings	2022-07-18	English
Global Leader IFF and Microba Reach First Milestone 2 pages 201.8KB Regulatory Filings	2022-07-03	English
Genova Diagnostics Partnership Commences in the US 2 pages 660.4KB Regulatory Filings	2022-06-29	English
G42 Healthcare Partnership Commences Operation 2 pages 186.7KB Regulatory Filings	2022-06-27	English
Next Generation Product Released to Health Professionals 1 Regulatory Filings	2022-06-22	English
Application for quotation of securities - MAP 6 pages 27.2KB Regulatory Filings	2022-06-14	English
Microba & Ginkgo Commence Therapeutics Program 2 pages 202.0KB Regulatory Filings	2022-06-07	English
Release of Restricted Securities from Escrow 1 page Regulatory Filings	2022-06-05	English
Microba Appoints CRO for IBD Clinical Trial 2 pages 662.4KB Regulatory Filings	2022-05-26	English
Partnership signed with nib-backed Midnight Health 2 pages 190.6KB Regulatory Filings	2022-05-25	English
Change in substantial holding 2 pages 817.7KB Regulatory Filings	2022-05-09	English
Microba Appoints Senior US Sales Lead 1 page 159.0K Regulatory Filings	2022-05-08	English
Microba Accelerates Cancer Program 2 pages 206.5KB Regulatory Filings	2022-05-04	English
International Conference Presentation 15 pages 1.8MB Regulatory Filings	2022-04-28	English
Change of Director's Interest Notice - Pasquale Rombola 2 pages 215.2KB Regulatory Filings	2022-04-12	English
Change of Director's Interest Notice - Prof Ian Frazer 2 pages 216.4KB Regulatory Filings	2022-04-12	English
Microba CSO presents to US industry conference 31 pages 3.0MB Regulatory Filings	2022-04-12	English
ShareCafe Small Cap Hidden Gems Presentation 1 page Regulatory Filings	2022-04-06	English
Microba Investor Presentation - April 2022 45 pages 3.7MB Regulatory Filings	2022-04-05	English
Investor Webinar with Profs Ian Frazer & Gene Tyson 1 Regulatory Filings	2022-04-05	English
Microba Appoints New Therapeutics Head 2 pages 160.7KB Regulatory Filings	2022-04-05	English
Becoming a substantial holder 2 pages 604.3KB Regulatory Filings	2022-04-05	English
Becoming a substantial holder 3 pages 41.8KB Regulatory Filings	2022-04-04	English
Becoming a substantial holder 2 pages 458.3KB Regulatory Filings	2022-04-04	English
Becoming a substantial holder 2 pages 89.8KB Regulatory Filings	2022-04-04	English
Becoming a substantial holder 2 pages 76.5KB Regulatory Filings	2022-04-04	English
Becoming a substantial holder 54 pages 15.6MB Regulatory Filings	2022-04-04	English
Becoming a substantial holder 3 pages 552.1KB Regulatory Filings	2022-04-04	English
Microba Completes Successful IPO 3 pages 175.8KB Regulatory Filings	2022-04-04	English
Initial Director's Interest Notice - Mr Pasquale Rombola 2 pages 186.4KB Regulatory Filings	2022-04-03	English
Initial Director's Interest Notice - Prof Ian Frazer 2 pages 186.7KB Regulatory Filings	2022-04-03	English
Initial Director's Interest Notice - Mr Richard Bund 2 pages 192.4KB Regulatory Filings	2022-04-03	English
Initial Director's Interest Notice - Dr Hyungtae Kim 2 pages 185.6KB Regulatory Filings	2022-04-03	English
Initial Director's Interest Notice- Dr Caroline Popper 2 pages 181.9KB Regulatory Filings	2022-04-03	English
Initial Director's Interest Notice - Prof Gene Tyson 2 pages 185.5KB Regulatory Filings	2022-04-03	English
ASX Notice - Admission to Official List 2 pages 454.6KB Regulatory Filings	2022-03-31	English
Appendix 1A 1 page 108.9KB Regulatory Filings	2022-03-31	English
Information Form and Checklist 19 pages 198.9KB Regulatory Filings	2022-03-31	English
Prospectus 218 pages 7.9MB Regulatory Filings	2022-03-31	English
Supplementary Prospectus 2 pages 149.4KB Regulatory Filings	2022-03-31	English
Constitution 61 pages 507.6KB Regulatory Filings	2022-03-31	English
30 June 2020 Financial Report 37 pages 7.1MB Regulatory Filings	2022-03-31	English
30 June 2021 Financial Report 38 pages 2.4MB Regulatory Filings	2022-03-31	English
31 December 2021 Half-year Financial Report 20 pages 2.3MB Regulatory Filings	2022-03-31	English
Employee Incentive Plan 46 pages 373.6KB Regulatory Filings	2022-03-31	English
Securities Trading Policy 10 pages 609.4KB Regulatory Filings	2022-03-31	English
Distribution Schedule 1 page 63.9KB Regulatory Filings	2022-03-31	English
Top 20 holders 2 pages 72.1KB Regulatory Filings	2022-03-31	English
Pre-Quotation Disclosure 3 pages 110.1KB Regulatory Filings	2022-03-31	English